Merit Medical Systems EBIT 2010-2024 | MMSI

Merit Medical Systems annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Merit Medical Systems EBIT for the quarter ending September 30, 2024 was $0.037B, a 6.04% increase year-over-year.
  • Merit Medical Systems EBIT for the twelve months ending September 30, 2024 was $0.153B, a 26.49% increase year-over-year.
  • Merit Medical Systems 2023 annual EBIT was $0.124B, a 41.55% increase from 2022.
  • Merit Medical Systems 2022 annual EBIT was $0.088B, a 43.74% increase from 2021.
  • Merit Medical Systems 2021 annual EBIT was $0.061B, a 3999.87% decline from 2020.
Merit Medical Systems Annual EBIT
(Millions of US $)
2023 $124
2022 $88
2021 $61
2020 $-2
2019 $15
2018 $59
2017 $33
2016 $35
2015 $38
2014 $40
2013 $28
2012 $30
2011 $33
2010 $17
2009 $33
Merit Medical Systems Quarterly EBIT
(Millions of US $)
2024-09-30 $37
2024-06-30 $46
2024-03-31 $36
2023-12-31 $34
2023-09-30 $35
2023-06-30 $29
2023-03-31 $26
2022-12-31 $30
2022-09-30 $19
2022-06-30 $23
2022-03-31 $15
2021-12-31 $22
2021-09-30 $16
2021-06-30 $9
2021-03-31 $14
2020-12-31 $16
2020-09-30 $0
2020-06-30 $-19
2020-03-31 $1
2019-12-31 $-3
2019-09-30 $-3
2019-06-30 $12
2019-03-31 $10
2018-12-31 $14
2018-09-30 $21
2018-06-30 $15
2018-03-31 $9
2017-12-31 $13
2017-09-30 $1
2017-06-30 $13
2017-03-31 $6
2016-12-31 $13
2016-09-30 $3
2016-06-30 $12
2016-03-31 $8
2015-12-31 $8
2015-09-30 $9
2015-06-30 $12
2015-03-31 $9
2014-12-31 $14
2014-09-30 $12
2014-06-30 $7
2014-03-31 $6
2013-12-31 $11
2013-09-30 $8
2013-06-30 $7
2013-03-31 $2
2012-12-31 $4
2012-09-30 $9
2012-06-30 $8
2012-03-31 $8
2011-12-31 $6
2011-09-30 $7
2011-06-30 $11
2011-03-31 $10
2010-12-31 $6
2010-09-30 $-3
2010-06-30 $9
2010-03-31 $6
2009-12-31 $8
2009-09-30 $8
2009-06-30 $9
2009-03-31 $8
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.988B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71